drugset / Trial / NCT00832494
Phase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This study was designed to test the addition of DMXAA (now known as ASA404) to carboplatin and paclitaxel in patients with NSCLC.
Timeline
- Start
- 2004-09
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASA404 | Unknown | 600 mg/m2 | — |
| Subject | ASA404 | Unknown | 1200 mg/m2 | — |
| Subject | ASA404 | Unknown | 1800 mg/m2 | — |
| Background | Carboplatin | Small molecule | 6 unknown | — |
| Background | Paclitaxel | Small molecule | 175 mg/m2 | — |